Works matching AU Inwards, David

Results: 112
    1
    2
    3
    4
    5
    6

    PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 5, p. 1, doi. 10.1038/s41408-022-00649-x
    By:
    • Desai, Sanjal H.;
    • Pederson, Levi;
    • LaPlant, Betsy;
    • Mwangi, Raphael;
    • Maurer, Matthew;
    • Young, Jason R.;
    • Macon, William R.;
    • King, Rebecca L.;
    • Wang, Yucai;
    • Cerhan, James R.;
    • Feldman, Andrew;
    • Inwards, David J.;
    • Micallef, Ivana;
    • Johnston, Patrick;
    • Porrata, Luis F.;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Nowakowski, Grzegorz S.
    Publication type:
    Article
    7

    Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00616-6
    By:
    • King, Rebecca L.;
    • Gupta, Alia;
    • Kurtin, Paul J.;
    • Ding, Wei;
    • Call, Timothy G.;
    • Rabe, Kari G.;
    • Kenderian, Saad S.;
    • Leis, Jose F.;
    • Wang, Yucai;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Kay, Neil. E.;
    • Koehler, Amber;
    • Ansell, Stephen M.;
    • Inwards, David J.;
    • Habermann, Thomas M.;
    • Shi, Min;
    • Hanson, Curtis A.;
    • Howard, Matthew T.;
    • Parikh, Sameer A.
    Publication type:
    Article
    8

    Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 9, p. 1, doi. 10.1038/s41408-021-00542-z
    By:
    • Desai, Sanjal H.;
    • LaPlant, Betsy;
    • Macon, William R.;
    • King, Rebecca L.;
    • Wang, Yucai;
    • Inwards, David J.;
    • Micallef, Ivana;
    • Johnston, Patrick B.;
    • Porrata, Luis F.;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Nowakowski, Grzegorz S.
    Publication type:
    Article
    9
    10
    11

    Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysis.

    Published in:
    Blood Cancer Journal, 2019, v. 9, n. 12, p. 1, doi. 10.1038/s41408-019-0261-1
    By:
    • Shah, Nirav N.;
    • Ahn, Kwang Woo;
    • Litovich, Carlos;
    • Sureda, Anna;
    • Kharfan-Dabaja, Mohamed A.;
    • Awan, Farrukh T.;
    • Ganguly, Siddhartha;
    • Gergis, Usama;
    • Inwards, David;
    • Karmali, Reem;
    • Lazaryan, Alexsandr;
    • Lekakis, Lazaros;
    • Munshi, Pashna;
    • Nathan, Sunita;
    • Saad, Ayman A.;
    • Solh, Melhem;
    • Steinberg, Amir;
    • Vij, Ravi;
    • Wood, William A.;
    • Fenske, Timothy S.
    Publication type:
    Article
    12

    Central nervous system involvement by mantle cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 2, p. 371, doi. 10.1080/10428194.2022.2148211
    By:
    • McLaughlin, Nicole;
    • Wang, Yucai;
    • Witzig, Thomas;
    • Villasboas, Jose;
    • Habermann, Thomas;
    • Inwards, David;
    • Bennani, Nora;
    • Thanarajasingam, Gita;
    • Nowakowski, Grzegorz;
    • Porrata, Luis;
    • Thompson, Carrie;
    • Micallef, Ivana;
    • Johnston, Patrick;
    • Ansell, Stephen;
    • Paludo, Jonas
    Publication type:
    Article
    13
    14

    Predictors of short-term survival in Waldenström Macroglobulinemia.

    Published in:
    2020
    By:
    • Ruan, Gordon;
    • Zanwar, Saurabh;
    • Abeykoon, Jithma P.;
    • Ansell, Stephen M.;
    • Gertz, Morie;
    • Go, Ronald S.;
    • Muchtar, Eli;
    • Gonsalves, Wilson I.;
    • Paludo, Jonas;
    • Thanarajasingam, Gita;
    • Inwards, David J.;
    • Thompson, Carrie A.;
    • Habermann, Thomas M.;
    • Lin, Yi;
    • Nowakowski, Grzegorz S.;
    • Bisneto, Jose C. Villasboas;
    • Dispenzieri, Angela;
    • Lacy, Martha Q.;
    • Buadi, Francis K.;
    • Dingli, David
    Publication type:
    Letter
    15
    16

    A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2018, v. 59, n. 9, p. 2128, doi. 10.1080/10428194.2017.1416368
    By:
    • Sonbol, Mohamad Bassam;
    • Hilal, Talal;
    • Rosenthal, Allison C.;
    • Leis, Jose F.;
    • Northfelt, Donald W.;
    • Bergsagel, Peter Leif;
    • Reeder, Craig B.;
    • Dueck, Amylou C.;
    • Kosiorek, Heidi E.;
    • Ginos, Brenda F.;
    • Conley, Christopher R.;
    • Gano, Katherine M.;
    • Nichols, Craig S.;
    • Johnston, Patrick B.;
    • Habermann, Thomas M.;
    • Inwards, David J.;
    • Witzig, Thomas E.;
    • Ansell, Stephen M.
    Publication type:
    Article
    17

    Survival in patients with limited-stage peripheral T-cell lymphomas.

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 6, p. 1665, doi. 10.3109/10428194.2014.963078
    By:
    • Briski, Robert;
    • Feldman, Andrew L.;
    • Bailey, Nathaniel G.;
    • Lim, Megan S.;
    • Ristow, Kay;
    • Habermann, Thomas M.;
    • Macon, William R.;
    • Inwards, David J.;
    • Colgan, Joseph P.;
    • Nowakowski, Grzegorz S.;
    • Kaminski, Mark S.;
    • Witzig, Thomas E.;
    • Ansell, Stephen M.;
    • Wilcox, Ryan A.
    Publication type:
    Article
    18
    19

    Peripheral blood absolute lymphocyte/monocyte ratio during rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone treatment cycles predicts clinical outcomes in diffuse large B-cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2014, v. 55, n. 12, p. 2728, doi. 10.3109/10428194.2014.893313
    By:
    • Porrata, Luis F.;
    • Ristow, Kay M.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Colgan, Joseph P.;
    • Inwards, David J.;
    • Ansell, Stephen M.;
    • Micallef, Ivana N.;
    • Johnston, Patrick B.;
    • Nowakowski, Grzegorz;
    • Thompson, Carrie A.;
    • Markovic, Svetomir N.
    Publication type:
    Article
    20

    A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulin.

    Published in:
    Leukemia & Lymphoma, 2013, v. 54, n. 8, p. 1713, doi. 10.3109/10428194.2012.753444
    By:
    • Larsen, Jeremy T.;
    • Hogan, William J.;
    • Micallef, Ivana N.;
    • Dispenzieri, Angela;
    • Gertz, Morie A.;
    • Inwards, David J.;
    • Tun, Han W.;
    • Roy, Vivek;
    • Geyer, Susan M.;
    • Allred, Jacob B.;
    • Wu, Wenting;
    • Ansell, Stephen M.;
    • Elliott, Michelle A.;
    • Tefferi, Ayalew;
    • Porrata, Luis F.;
    • Gastineau, Dennis A.;
    • Lacy, Martha Q.;
    • Litzow, Mark R.
    Publication type:
    Article
    21
    22
    23
    24

    Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 3, p. 432, doi. 10.1002/ajh.26807
    By:
    • Chohan, Karan L.;
    • Paludo, Jonas;
    • Vallumsetla, Nishanth;
    • Larson, Dirk;
    • King, Rebecca L.;
    • He, Rong;
    • Gonsalves, Wilson;
    • Inwards, David;
    • Witzig, Thomas E.;
    • Swaika, Abhisek;
    • Jain, Tania;
    • Leung, Nelson;
    • Ailawadhi, Sikander;
    • Reeder, Craig B.;
    • Lacy, Martha Q.;
    • Rajkumar, S. Vincent;
    • Kumar, Shaji;
    • Kyle, Robert A.;
    • Gertz, Morie A.;
    • Ansell, Stephen M.
    Publication type:
    Article
    25

    Lines of therapy before autologous stem cell transplant and CAR‐T affect outcomes in aggressive Non‐Hodgkin's lymphoma.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 10, p. E386, doi. 10.1002/ajh.26293
    By:
    • Khurana, Arushi;
    • Hathcock, Matthew;
    • Habermann, Thomas M.;
    • Al Saleh, Abdullah S.;
    • Gandhi, Sangeetha;
    • Truong, Tuan;
    • Bennani, N. Nora;
    • Paludo, Jonas;
    • Villasboas, Jose C.;
    • Ansell, Stephen M.;
    • Inwards, David J.;
    • Porrata, Luis F.;
    • Johnston, Patrick B.;
    • Micallef, Ivana;
    • Lin, Yi
    Publication type:
    Article
    26
    27

    Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 8, p. 979, doi. 10.1002/ajh.26230
    By:
    • Boddicker, Nicholas J.;
    • Larson, Melissa C.;
    • Castellino, Alessia;
    • Herrmann, Joerg;
    • Inwards, David J.;
    • Thanarajasingam, Gita;
    • Maurer, Matthew J.;
    • Allmer, Cristine;
    • Witzig, Thomas E.;
    • Nowakowski, Grzegorz S.;
    • Habermann, Thomas M.;
    • Villarraga, Hector R.;
    • Slager, Susan L.;
    • Cerhan, James R.;
    • Thompson, Carrie A.
    Publication type:
    Article
    28

    Assessment of fixed‐duration therapies for treatment‐naïve Waldenström macroglobulinemia.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 8, p. 945, doi. 10.1002/ajh.26210
    By:
    • Abeykoon, Jithma P.;
    • Zanwar, Saurabh;
    • Ansell, Stephen M.;
    • Muchtar, Eli;
    • He, Rong;
    • Greipp, Patricia T.;
    • King, Rebecca L.;
    • Ailawadhi, Sikander;
    • Paludo, Jonas;
    • Larsen, Jeremy T.;
    • Habermann, Thomas M.;
    • Inwards, David;
    • Go, Ronald S.;
    • Thanarajasingam, Gita;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Thompson, Carrie A.;
    • Witzig, Thomas E.;
    • Lacy, Martha;
    • Gonsalves, Wilson
    Publication type:
    Article
    29

    Single‐agent cladribine as an effective front‐line therapy for adults with Langerhans cell histiocytosis.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 5, p. E146, doi. 10.1002/ajh.26119
    By:
    • Goyal, Gaurav;
    • Abeykoon, Jithma P.;
    • Hu, Marie;
    • Young, Jason R.;
    • Shah, Mithun V.;
    • Bennani, N. Nora;
    • Call, Timothy G.;
    • Hook, C. Christopher;
    • Pardanani, Animesh;
    • Inwards, David J.;
    • Vassallo, Robert;
    • Ryu, Jay H.;
    • Tobin, W. Oliver;
    • Koster, Matthew J.;
    • Davidge‐Pitts, Caroline J.;
    • Ravindran, Aishwarya;
    • Rech, Karen L.;
    • Go, Ronald S.
    Publication type:
    Article
    30

    Characteristics of late transplant‐associated thrombotic microangiopathy in patients who underwent allogeneic hematopoietic stem cell transplantation.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 10, p. 1170, doi. 10.1002/ajh.25922
    By:
    • Heybeli, Cihan;
    • Sridharan, Meera;
    • Alkhateeb, Hassan B.;
    • Villasboas Bisneto, Jose C.;
    • Buadi, Francis K.;
    • Chen, Dong;
    • Dingli, David;
    • Dispenzieri, Angela;
    • Gertz, Morie A.;
    • Go, Ronald S.;
    • Hashmi, Shahrukh K.;
    • Hayman, Suzanne R.;
    • Hogan, William J.;
    • Inwards, David J.;
    • Kenderian, Saad S.;
    • Kumar, Shaji K.;
    • Litzow, Mark R.;
    • Porrata, Luis F.;
    • Lacy, Martha Q.;
    • Micallef, Ivana N.
    Publication type:
    Article
    31

    Impact of MYD88<sup>L265P</sup> mutation status on histological transformation of Waldenström Macroglobulinemia.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 3, p. 274, doi. 10.1002/ajh.25697
    By:
    • Zanwar, Saurabh;
    • Abeykoon, Jithma P.;
    • Durot, Eric;
    • King, Rebecca;
    • Perez Burbano, Gabriela E.;
    • Kumar, Shaji;
    • Gertz, Morie A.;
    • Quinquenel, Anne;
    • Delmer, Alain;
    • Gonsalves, Wilson;
    • Cornillet‐Lefebvre, Pascale;
    • He, Rong;
    • Warsame, Rahma;
    • Buadi, Francis K.;
    • Novak, Anne J.;
    • Greipp, Patricia T.;
    • Inwards, David;
    • Habermann, Thomas M.;
    • Micallef, Ivana;
    • Go, Ronald
    Publication type:
    Article
    32

    Host genetic variation in tumor necrosis factor and nuclear factor‐κB pathways and overall survival in mantle cell lymphoma: A discovery and replication study.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 6, p. E153, doi. 10.1002/ajh.25451
    By:
    • Wang, Yucai;
    • Habermann, Thomas M.;
    • Wang, Sophia S.;
    • Maurer, Matthew J.;
    • Sarangi, Vivekananda;
    • Link, Brian K.;
    • Feldman, Andrew L.;
    • Inwards, David J.;
    • Witzig, Thomas E.;
    • Cozen, Wendy;
    • Rothman, Nathaniel;
    • Asmann, Yan;
    • Slager, Susan L.;
    • Cerhan, James R.
    Publication type:
    Article
    33

    Role of systemic high‐dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990‐2018.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 3, p. 291, doi. 10.1002/ajh.25350
    By:
    • Castellino, Alessia;
    • Pulido, Jose S.;
    • Johnston, Patrick B.;
    • Ristow, Kay M.;
    • Nora Bennani, N.;
    • Inwards, David J.;
    • Macon, William R.;
    • Micallef, Ivana N. M.;
    • King, Rebecca L.;
    • Salomao, Diva R.;
    • Witzig, Thomas E.;
    • Habermann, Thomas M.;
    • Nowakowski, Grzegorz S.
    Publication type:
    Article
    34

    Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 11, p. 1384, doi. 10.1002/ajh.25254
    By:
    • Abeykoon, Jithma P.;
    • Zanwar, Saurabh;
    • Ansell, Stephen M.;
    • Winters, Jeffrey;
    • Gertz, Morie A.;
    • King, Rebecca L.;
    • Murray, David;
    • Habermann, Thomas;
    • Dingli, David;
    • Muchtar, Eli;
    • Go, Ronald S.;
    • Leung, Nelson;
    • Inwards, David J;
    • Buadi, Francis K.;
    • Dispenzieri, Angela;
    • Lacy, Martha Q.;
    • Lin, Yi;
    • Gonsalves, Wilson I.;
    • Kourelis, Taxiarchis;
    • Witzig, Thomas E.
    Publication type:
    Article
    35

    Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 5, p. 448, doi. 10.1002/ajh.24671
    By:
    • Bennani, N. Nora;
    • LaPlant, Betsy R.;
    • Ansell, Stephen M.;
    • Habermann, Thomas. M.;
    • Inwards, David J.;
    • Micallef, Ivana N.;
    • Johnston, Patrick B.;
    • Porrata, Luis F.;
    • Colgan, Joseph P.;
    • Markovic, Svetomir N.;
    • Nowakowski, Grzegorz S.;
    • Macon, William R.;
    • Reeder, Craig B.;
    • Mikhael, Joseph R.;
    • Northfelt, Donald W.;
    • Ghobrial, Irene M.;
    • Witzig, Thomas E.
    Publication type:
    Article
    36

    A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 5, p. 467, doi. 10.1002/ajh.24693
    By:
    • Rosenthal, Allison;
    • Dueck, Amylou C.;
    • Ansell, Stephen;
    • Gano, Katherine;
    • Conley, Christopher;
    • Nowakowski, Grzegorz S.;
    • Camoriano, John;
    • Leis, Jose F.;
    • Mikhael, Joseph R.;
    • Keith Stewart, A.;
    • Inwards, David;
    • Dingli, David;
    • Kumar, Shaji;
    • Noel, Pierre;
    • Gertz, Morie;
    • Porrata, Luis;
    • Russell, Stephen;
    • Colgan, Joseph;
    • Fonseca, Rafael;
    • Habermann, Thomas M.
    Publication type:
    Article
    37

    Early event status informs subsequent outcome in newly diagnosed follicular lymphoma.

    Published in:
    American Journal of Hematology, 2016, v. 91, n. 11, p. 1096, doi. 10.1002/ajh.24492
    By:
    • Maurer, Matthew J.;
    • Bachy, Emmanuel;
    • Ghesquières, Hervé;
    • Ansell, Stephen M.;
    • Nowakowski, Grzegorz S.;
    • Thompson, Carrie A.;
    • Inwards, David J.;
    • Allmer, Cristine;
    • Chassagne-Clément, Catherine;
    • Nicolas-Virelizier, Emmanuelle;
    • Sebban, Catherine;
    • Lebras, Laure;
    • Sarkozy, Clementine;
    • Macon, William R.;
    • Feldman, Andrew L.;
    • Syrbu, Sergei I.;
    • Traverse-Glehan, Alexandra;
    • Coiffier, Bertrand;
    • Slager, Susan L.;
    • Weiner, George J.
    Publication type:
    Article
    38

    Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non- Hodgkin lymphoma.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 12, p. 1116, doi. 10.1002/ajh.23839
    By:
    • Witzig, Thomas E.;
    • Maurer, Matthew J.;
    • Habermann, Thomas M.;
    • Link, Brian K.;
    • Micallef, Ivana N.M.;
    • Nowakowski, Grzegorz S.;
    • Ansell, Stephen M.;
    • Colgan, Joseph P.;
    • Inwards, David J.;
    • Porrata, Luis F.;
    • Markovic, Svetomir N.;
    • Johnston, Patrick B.;
    • Lin, Yi;
    • Thompson, Carrie;
    • Gupta, Mamta;
    • Katzmann, Jerry A.;
    • Cerhan, James R.
    Publication type:
    Article
    39

    A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and <sup>90</sup>yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma.

    Published in:
    American Journal of Hematology, 2013, v. 88, n. 7, p. 589, doi. 10.1002/ajh.23460
    By:
    • Witzig, Thomas E.;
    • Wiseman, Gregory A.;
    • Maurer, Matthew J.;
    • Habermann, Thomas M.;
    • Micallef, Ivana N.M.;
    • Nowakowski, Grzegorz S.;
    • Ansell, Stephen M.;
    • Colgan, Joseph P.;
    • Inwards, David J.;
    • Porrata, Luis F.;
    • Link, Brian K.;
    • Zent, Clive S.;
    • Johnston, Patrick B.;
    • Shanafelt, Tait D.;
    • Allmer, Cristine;
    • Asmann, Yan W.;
    • Gupta, Mamta;
    • Ballas, Zuhair K.;
    • Smith, Brian J.;
    • Weiner, George J.
    Publication type:
    Article
    40
    41

    A Phase II study of <sup>153</sup>Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.

    Published in:
    American Journal of Hematology, 2010, v. 85, n. 6, p. 409, doi. 10.1002/ajh.21696
    By:
    • Dispenzieri, Angela;
    • Wiseman, Gregory A.;
    • Lacy, Martha Q.;
    • Hayman, Suzanne R.;
    • Kumar, Shaji K.;
    • Buadi, Francis;
    • Dingli, David;
    • Laumann, Krista M.;
    • Allred, Jake;
    • Geyer, Susan M.;
    • Litzow, Mark R.;
    • Gastineau, Dennis A.;
    • Inwards, David J.;
    • Micallef, Ivana N.;
    • Ansell, Stephen M.;
    • Porrata, Luis;
    • Elliott, Michelle A.;
    • Johnston, Patrick B.;
    • Hogan, William J.;
    • Gertz, Morie A.
    Publication type:
    Article
    42
    43
    44

    Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00942-3
    By:
    • Bock, Allison M.;
    • Gile, Jennifer J.;
    • Larson, Melissa C.;
    • Poonsombudlert, Kittika;
    • Tawfiq, Reema K.;
    • Maliske, Seth;
    • Maurer, Matthew J.;
    • Kabat, Brian F.;
    • Paludo, Jonas;
    • Inwards, David J.;
    • Ayyappan, Sabarish;
    • Link, Brian K.;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Nowakowski, Grzegorz S.;
    • Cerhan, James R.;
    • Farooq, Umar;
    • Wang, Yucai
    Publication type:
    Article
    45
    46

    Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic Experience.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. e815, doi. 10.1016/j.clml.2022.04.009
    By:
    • Kuhlman, Justin J.;
    • Moustafa, Muhamad Alhaj;
    • Jiang, Liuyan;
    • Iqbal, Madiha;
    • Seegobin, Karan;
    • Wolcott, Zoe;
    • Ayala, Ernesto;
    • Ansell, Steve;
    • Rosenthal, Allison;
    • Paludo, Jonas;
    • Micallef, Ivana;
    • Johnston, Patrick;
    • Inwards, David;
    • Habermann, Thomas;
    • Kharfan-Dabaja, Mohamed;
    • Witzig, Thomas E.;
    • Nowakowski, Grzegorz S.;
    • Tun, Han W.
    Publication type:
    Article
    47

    Impact of Cell of Origin on Outcomes After Autologous Hematopoietic Cell Transplant in Diffuse Large B-Cell Lymphoma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 2, p. e89, doi. 10.1016/j.clml.2021.08.011
    By:
    • Iqbal, Madiha;
    • Castano, Yennifer Gil;
    • Paludo, Jonas;
    • Rosenthal, Allison;
    • Zhuo Li;
    • Beltran, Manuel;
    • Moustafa, Muhamad Alhaj;
    • Inwards, David;
    • Porrata, Luis;
    • Micallef, Ivana;
    • Bisneto, Jose C. Villasboas;
    • Johnston, Patrick;
    • Ansell, Stephen M.;
    • Reeder, Craig;
    • Murthy, Hemant;
    • Roy, Vivek;
    • Foran, James;
    • Tun, Han W.;
    • Kharfan-Dabaja, Mohamed A.;
    • Ayala, Ernesto
    Publication type:
    Article
    48
    49

    IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S401, doi. 10.1016/S2152-2650(21)01906-6
    By:
    • Abeykoon, Jithma;
    • Zanwar, Saurabh;
    • Ansell, Stephen;
    • Muchtar, Eli;
    • Rong He;
    • Greipp, Patricia;
    • King, Rebecca;
    • Ailawadhi, Sikander;
    • Paludo, Jonas;
    • Larsen, Jeremy;
    • Habermann, Thomas;
    • Inwards, David;
    • Go, Ronald;
    • Thanarajasingam, Gita;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Thompson, Carrie;
    • Witzig, Thomas;
    • Lacy, Martha;
    • Gonsalves, Wilson
    Publication type:
    Article
    50